Keywords: جهش JAK2; JAK2 mutation; stroke; cerebral sinus thrombosis; myeloproliferative neoplasms;
مقالات ISI جهش JAK2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جهش JAK2; nowotwory mieloproliferacyjne; mutacje JAK2; mutacja JAK2 V617F; czerwienica prawdziwa; nadpÅytkowoÅÄ samoistna; Myeloproliferative neoplasm; JAK2 mutation; JAK2 V617F mutation; Polycythemia vera; Essential thrombocythemia;
Keywords: جهش JAK2; Myeloproliferative neoplasms; Polycythemia vera; Essential thrombocytosis; Myelofibrosis; JAK2 mutation;
Keywords: جهش JAK2; Bone marrow fibrosis; Fibrosis regression; Myelofibrosis; Allogeneic stem cell transplantation; JAK2 mutation
Keywords: جهش JAK2; myeloproliferative neoplasm; leukemic transformation; leukemia etiology; polycythemia vera; essential thrombocythemia; primary myelofibrosis; antineoplastic agents; alkylators; hydroxyurea; radioactive phosphorous; X-ray treatment; JAK2 mutation; risk fac
BCR/ABL1-negative, triple-negative, myeloproliferative neoplasm with a hitherto undescribed, isolated, SH2B3 (LNK) gene mutation: A case report
Keywords: جهش JAK2; Myeloproliferative neoplasm; SH2B3 (LNK) mutation; JAK2 mutation; CALR mutation; MPL mutation;
Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis
Keywords: جهش JAK2; JAK2 mutation; Local thrombolysis; Portal vein thrombosis; Transjugular intrahepatic portosystemic shunt;
Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation
Keywords: جهش JAK2; CALR p.K385fs*47 mutation; Germ line; JAK2 mutation; Myeloproliferative neoplasms; Thrombocythosis;
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation
Keywords: جهش JAK2; Myeloproliferative neoplasms; Haplotype; Genetic polymorphism; JAK2 mutation; CALR mutation
Caractéristiques clinico-biologiques des patients avec thrombocytémie essentielle en fonction de leur statut mutationnel JAK2 ou CALR : étude monocentrique de 40 patients et revue de la littérature
Keywords: جهش JAK2; Mutation CALR; Mutation JAK2; Thrombocytémie essentielle; Thrombose; Syndromes myéloprolifératifsCALR mutation; JAK2 mutation; Essential thrombocythemia; Thrombosis; Myeloproliferative disorders
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis
Keywords: جهش JAK2; Myelofibrosis; JAK2 mutation; AZD1480;
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group
Keywords: جهش JAK2; Hydroxyurea; Interferon; JAK2 mutation; Polycythemia vera; Ruxolitinib
Thromboses veineuses à répétition et syndrome myéloprolifératif : positivité secondaire d'une mutation JAK2 cinq ans après l'événement initial
Keywords: جهش JAK2; Thrombose veineuse profonde; Maladie de Vaquez; Mutation JAK2; Culture de progéniteurs; Thrombocytémie essentielle; Deep vein thrombosis; Polycythemia vera; JAK2 mutation; Culture of progenitor cells; Essential thrombocythemia;
Stare i nowe czynniki ryzyka zakrzepicy u chorych z nadpÅytkowoÅciÄ
samoistnÄ
Keywords: جهش JAK2; nadpÅytkowoÅÄ samoistna; powikÅania zakrzepowe; mutacja JAK2; sercowo-naczyniowe czynniki ryzyka zakrzepicy; trombofilia; Essential thrombocythemia; Thrombotic complications; JAK2 mutation; Cardiovascular risk factors; Thrombophilia;
JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms
Keywords: جهش JAK2; Essential thrombocythemia; JAK2 mutation; MPNs; Polycythemia vera; Primary myelofibrosis
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia
Keywords: جهش JAK2; Chronic myelomonocytic leukemia; Myeloproliferative neoplasms; SRSF2 mutation; JAK2 mutation; Bone marrow biopsy
Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia
Keywords: جهش JAK2; Essential thrombocythemia; Polycythemia vera; JAK2 mutation; Interleukin-23; Interleukin-22; Interleukin-10
Novel Risk Factors for Venous Thromboembolism
Keywords: جهش JAK2; Metabolic syndrome; JAK2 mutation; Hyperthyroidism; Cushing syndrome; Venous thromboembolism; Risk factors;
Trombosis portal
Keywords: جهش JAK2; Síndrome mieloproliferativo; Mutación JAK2; Hipertensión portal; Hemorragia digestiva varicealMyeloproliferative syndrome; JAK2 mutation; Portal hypertension; Gastrointestinal variceal bleeding
JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN)
Keywords: جهش JAK2; Chronic lymphocytic leukemia (CLL); Myeloproliferative neoplasm (MPN); JAK2 mutation
Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: Clinical implications
Keywords: جهش JAK2; Chronic myeloproliferative disorders; Philadelphia negative; JAK2 mutation; JAK2V617F; JAK2 exon 12; Clinical implications
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm
Keywords: جهش JAK2; Atypical chronic myeloid leukemia; Atypical CML; Myelodysplastic/myeloproliferative neoplasms; JAK2 mutation; Bone marrow trephine biopsy
The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms
Keywords: جهش JAK2; JAK2 mutation; JAK2 translocation; Myeloproliferative neoplasms; Chronic myeloproliferative disorder; Acute lymphoblastic leukemia; Acute myeloid leukemia; Myelodysplastic syndrome; Lymphoma; WHO classification
The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age
Keywords: جهش JAK2; JAK2 mutation; myeloproliferative disorders; essential thrombocytosis; polycythemia vera; idiopathic myelofibrosis
Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: Clinical implications
Keywords: جهش JAK2; Chronic myeloproliferative disorders; Cytogenetics; Chromosomal abnormalities; Molecular changes; JAK2 mutation; Clinical implications
Mutation screening for JAK2V617F: When to order the test and how to interpret the results
Keywords: جهش JAK2; JAK2 mutation; Polycythemia; Thrombocytosis; Diagnosis